vs
Side-by-side financial comparison of Bloomin' Brands, Inc. (BLMN) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Bloomin' Brands, Inc. is the larger business by last-quarter revenue ($975.2M vs $493.8M, roughly 2.0× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -1.4%, a 8.2% gap on every dollar of revenue. On growth, Bloomin' Brands, Inc. posted the faster year-over-year revenue change (0.3% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -4.5%).
Bloomin' Brands, Inc. is a restaurant holding company that owns several American casual dining restaurant chains. The company was established in 1988 in Tampa, Florida, where it is headquartered.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
BLMN vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $975.2M | $493.8M |
| Net Profit | $-13.5M | $33.7M |
| Gross Margin | 70.2% | — |
| Operating Margin | -1.4% | 9.9% |
| Net Margin | -1.4% | 6.8% |
| Revenue YoY | 0.3% | -1.7% |
| Net Profit YoY | 83.0% | 10.5% |
| EPS (diluted) | $-0.16 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $975.2M | $493.8M | ||
| Q3 25 | $928.8M | $492.9M | ||
| Q2 25 | $1.0B | $468.8M | ||
| Q1 25 | $1.0B | $458.4M | ||
| Q4 24 | $972.0M | $502.4M | ||
| Q3 24 | $910.0M | $511.2M | ||
| Q2 24 | $999.4M | $504.3M | ||
| Q1 24 | $1.1B | $495.1M |
| Q4 25 | $-13.5M | $33.7M | ||
| Q3 25 | $-45.9M | $71.7M | ||
| Q2 25 | $25.4M | $39.3M | ||
| Q1 25 | $42.2M | $20.7M | ||
| Q4 24 | $-79.5M | $30.5M | ||
| Q3 24 | $6.9M | $19.4M | ||
| Q2 24 | $28.4M | $-153.0M | ||
| Q1 24 | $-83.9M | $4.0M |
| Q4 25 | 70.2% | — | ||
| Q3 25 | 70.4% | — | ||
| Q2 25 | 70.2% | — | ||
| Q1 25 | 70.1% | — | ||
| Q4 24 | 71.6% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 70.5% | — | ||
| Q1 24 | 70.5% | — |
| Q4 25 | -1.4% | 9.9% | ||
| Q3 25 | -3.9% | 13.8% | ||
| Q2 25 | 3.0% | 12.8% | ||
| Q1 25 | 5.5% | 7.0% | ||
| Q4 24 | 1.7% | 7.8% | ||
| Q3 24 | 0.9% | 6.6% | ||
| Q2 24 | 4.4% | -31.3% | ||
| Q1 24 | 6.6% | 3.2% |
| Q4 25 | -1.4% | 6.8% | ||
| Q3 25 | -4.9% | 14.5% | ||
| Q2 25 | 2.5% | 8.4% | ||
| Q1 25 | 4.0% | 4.5% | ||
| Q4 24 | -8.2% | 6.1% | ||
| Q3 24 | 0.8% | 3.8% | ||
| Q2 24 | 2.8% | -30.3% | ||
| Q1 24 | -7.8% | 0.8% |
| Q4 25 | $-0.16 | $0.40 | ||
| Q3 25 | $-0.54 | $0.84 | ||
| Q2 25 | $0.30 | $0.46 | ||
| Q1 25 | $0.50 | $0.24 | ||
| Q4 24 | $-0.93 | $0.37 | ||
| Q3 24 | $0.08 | $0.23 | ||
| Q2 24 | $0.32 | $-1.84 | ||
| Q1 24 | $-0.96 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.5M | $375.2M |
| Total DebtLower is stronger | $787.4M | $570.5M |
| Stockholders' EquityBook value | $333.6M | $865.9M |
| Total Assets | $3.2B | $2.2B |
| Debt / EquityLower = less leverage | 2.36× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $59.5M | $375.2M | ||
| Q3 25 | $66.5M | $340.1M | ||
| Q2 25 | $50.3M | $224.7M | ||
| Q1 25 | $57.7M | $99.0M | ||
| Q4 24 | $70.1M | $229.9M | ||
| Q3 24 | $83.6M | $103.8M | ||
| Q2 24 | $117.9M | $19.4M | ||
| Q1 24 | $131.7M | $8.0M |
| Q4 25 | $787.4M | $570.5M | ||
| Q3 25 | $962.2M | $577.2M | ||
| Q2 25 | $917.1M | $583.9M | ||
| Q1 25 | $917.6M | $590.5M | ||
| Q4 24 | $1.0B | $597.1M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $951.8M | — |
| Q4 25 | $333.6M | $865.9M | ||
| Q3 25 | $344.1M | $890.7M | ||
| Q2 25 | $397.2M | $833.8M | ||
| Q1 25 | $380.6M | $789.2M | ||
| Q4 24 | $135.5M | $764.9M | ||
| Q3 24 | $242.1M | $732.5M | ||
| Q2 24 | $286.8M | $706.5M | ||
| Q1 24 | $302.7M | $856.2M |
| Q4 25 | $3.2B | $2.2B | ||
| Q3 25 | $3.3B | $2.2B | ||
| Q2 25 | $3.3B | $2.1B | ||
| Q1 25 | $3.3B | $2.0B | ||
| Q4 24 | $3.4B | $2.2B | ||
| Q3 24 | $3.4B | $2.1B | ||
| Q2 24 | $3.4B | $2.0B | ||
| Q1 24 | $3.4B | $2.2B |
| Q4 25 | 2.36× | 0.66× | ||
| Q3 25 | 2.80× | 0.65× | ||
| Q2 25 | 2.31× | 0.70× | ||
| Q1 25 | 2.41× | 0.75× | ||
| Q4 24 | 7.58× | 0.78× | ||
| Q3 24 | 4.51× | — | ||
| Q2 24 | 3.49× | — | ||
| Q1 24 | 3.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $119.1M | $114.1M |
| Free Cash FlowOCF − Capex | $63.7M | — |
| FCF MarginFCF / Revenue | 6.5% | — |
| Capex IntensityCapex / Revenue | 5.7% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $96.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $119.1M | $114.1M | ||
| Q3 25 | $34.4M | $137.3M | ||
| Q2 25 | $49.7M | $137.2M | ||
| Q1 25 | $73.5M | $-117.5M | ||
| Q4 24 | $119.8M | $133.0M | ||
| Q3 24 | $-7.8M | $91.8M | ||
| Q2 24 | $42.4M | $107.0M | ||
| Q1 24 | $73.8M | $-125.2M |
| Q4 25 | $63.7M | — | ||
| Q3 25 | $-5.7M | — | ||
| Q2 25 | $11.1M | — | ||
| Q1 25 | $27.7M | — | ||
| Q4 24 | $66.7M | — | ||
| Q3 24 | $-67.3M | — | ||
| Q2 24 | $-12.1M | — | ||
| Q1 24 | $20.0M | — |
| Q4 25 | 6.5% | — | ||
| Q3 25 | -0.6% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | -7.4% | — | ||
| Q2 24 | -1.2% | — | ||
| Q1 24 | 1.9% | — |
| Q4 25 | 5.7% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 5.0% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 1.95× | 3.49× | ||
| Q1 25 | 1.74× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | -1.13× | 4.72× | ||
| Q2 24 | 1.49× | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLMN
| Food And Beverage | $958.0M | 98% |
| Franchiseand Other Revenue | $17.2M | 2% |
| International Franchise Segment | $7.8M | 1% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
